Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5274-65-7
2. Genapol 2
3. Oleth-2 [vandf]
4. Oleth-2 [inci]
5. Polyoxyl 2 Oleyl Ether
6. Oleth-2 [ii]
7. Brij 93
8. Diethylene Glycol Monooleyl Ether
9. Chemonic Oe-2 Ethoxylated Alcohol
10. 7l6r1sq6m0
11. 2-[2-[(z)-octadec-9-enoxy]ethoxy]ethanol
12. Ethanol, 2-(2-((9z)-9-octadecenyloxy)ethoxy)-
13. Ethanol, 2-(2-(9-octadecenyloxy)ethoxy)-, (z)-
14. Ethanol, 2-(2-((9z)-9-octadecen-1-yloxy)ethoxy)-
15. Unii-7l6r1sq6m0
16. Brij-92
17. Schembl2123908
18. Dtxsid201021510
19. Q27268502
Molecular Weight | 356.6 g/mol |
---|---|
Molecular Formula | C22H44O3 |
XLogP3 | 7.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 21 |
Exact Mass | 356.32904526 g/mol |
Monoisotopic Mass | 356.32904526 g/mol |
Topological Polar Surface Area | 38.7 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 254 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
26
PharmaCompass offers a list of Genapol 2 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Genapol 2 manufacturer or Genapol 2 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Genapol 2 manufacturer or Genapol 2 supplier.
PharmaCompass also assists you with knowing the Genapol 2 API Price utilized in the formulation of products. Genapol 2 API Price is not always fixed or binding as the Genapol 2 Price is obtained through a variety of data sources. The Genapol 2 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BRIJ 93 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BRIJ 93, including repackagers and relabelers. The FDA regulates BRIJ 93 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BRIJ 93 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BRIJ 93 supplier is an individual or a company that provides BRIJ 93 active pharmaceutical ingredient (API) or BRIJ 93 finished formulations upon request. The BRIJ 93 suppliers may include BRIJ 93 API manufacturers, exporters, distributors and traders.
BRIJ 93 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BRIJ 93 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BRIJ 93 GMP manufacturer or BRIJ 93 GMP API supplier for your needs.
A BRIJ 93 CoA (Certificate of Analysis) is a formal document that attests to BRIJ 93's compliance with BRIJ 93 specifications and serves as a tool for batch-level quality control.
BRIJ 93 CoA mostly includes findings from lab analyses of a specific batch. For each BRIJ 93 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BRIJ 93 may be tested according to a variety of international standards, such as European Pharmacopoeia (BRIJ 93 EP), BRIJ 93 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BRIJ 93 USP).